SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to surging trading volume and strong investor interest, fueled by a pivot from legacy hardware to a growth-oriented cybersecurity and IoT software model powered by QNX. The community is actively discussing the stock's transition into physical AI infrastructure, with shareholders debating the potential for long-term gains as the company ramps up subscription-based revenue and secures high-profile partnerships.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing a massive surge fueled by momentum traders and institutional capital following an endorsement from Nvidia's CEO, who identified the firm as a potential trillion-dollar entity. While the community is actively debating the sustainability of this rally and its parabolic structure, many are focused on the company's critical role in AI data center infrastructure as a primary driver of long-term sentiment.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is seeing significant attention from investors as it prepares for earnings, with expectations heavily focused on whether massive hyperscaler AI demand will justify further stock upside. Market sentiment remains highly active, with traders closely analyzing the potential for a blowout beat versus a post-earnings sell-off.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is experiencing a significant surge as investors rotate into AI and data center plays, with the stock gaining strong momentum amid speculation that major hyperscaler lease agreements are imminent. The community is actively discussing the stock's decoupling from Bitcoin, its pivot to high-performance computing, and the belief that the company is currently undervalued as it approaches a key technical resistance level.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks shares are seeing significant volatility following a quarterly earnings report that featured an revenue beat and raised guidance but was met with a sharp reversal as investors grappled with high valuations and acquisition-related costs. The community remains deeply divided, with some investors viewing the pullback as a buying opportunity supported by numerous analyst price target hikes, while others express caution over the stock's elevated P/E ratio and the transition toward AI-driven security.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing a sustained wave of bullish momentum driven by anticipation surrounding the R2 vehicle launch and ongoing accumulation by institutional investors. Community discourse remains heavily focused on potential short squeezes and expanded partnerships, with many participants actively looking past near-term resistance levels in favor of a long-term AI and software-led valuation thesis.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as the company heads into the upcoming ASCO annual meeting, where the community expects a major data reveal on their Alpha DaRT therapy for pancreatic cancer. Investors are actively discussing the stock's strong clinical progress, recent institutional price target increases, and the anticipation of upcoming trial milestones.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is attracting speculative interest as part of a broader rotation into nuclear energy, driven by the surging power demands of AI data centers. While some market participants express frustration over slow commercial milestones and management execution, community discussions remain focused on potential institutional contracts and the sector's role in the long-term energy infrastructure bottleneck.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging as investors cheer a record-breaking earnings report featuring significant revenue growth and raised financial guidance that suggests the stock is substantially undervalued. The community is actively discussing the company's strong commercial momentum, potential M&A prospects, and upcoming clinical catalysts that could accelerate its position as a major player in the MS treatment market.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is drawing intense investor attention as the community debates whether its massive capital expenditure on AI infrastructure will yield long-term revenue growth or continue to weigh on stock performance. Traders are closely monitoring the stock's support at key psychological levels while weighing fresh analyst upgrades against broader concerns about the ROI of aggressive AI investments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.

PRTKParatek Pharmaceuticals Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PRTK News